{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:58:16Z","timestamp":1791039496448,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,12,30]],"date-time":"2006-12-30T00:00:00Z","timestamp":1167436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2007,3,30]]},"DOI":"10.1245\/s10434-006-9226-2","type":"journal-article","created":{"date-parts":[[2006,12,29]],"date-time":"2006-12-29T22:57:10Z","timestamp":1167433030000},"page":"1416-1423","source":"Crossref","is-referenced-by-count":17,"title":["Down-Regulation of Pro-Apoptotic Genes is an Early Event in the Progression of Malignant Melanoma"],"prefix":"10.1245","volume":"14","author":[{"given":"Eric H.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Daud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Enkemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Yeatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon K.","family":"Sondak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Riker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,30]]},"reference":[{"key":"9226_CR1","unstructured":"Surveillance, epidemiology and end results (SEER) program public-use data (1973\u20132001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission"},{"key":"9226_CR2","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1200\/JCO.2005.00.695","volume":"23","author":"S Eschrich","year":"2005","unstructured":"Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 2005;23:3526\u201335","journal-title":"J Clin Oncol"},{"key":"9226_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00432-003-0434-x","volume":"129","author":"CM Frederiksen","year":"2003","unstructured":"Frederiksen CM, Knudsen S, Laurberg S, Orntoft TF. Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 2003;129:263\u201371","journal-title":"J Cancer Res Clin Oncol"},{"key":"9226_CR4","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1038\/sj.onc.1208984","volume":"24","author":"A Barrier","year":"2005","unstructured":"Barrier A, Lemoine A, Boelle PY, et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene 2005;24:6155\u201364","journal-title":"Oncogene"},{"key":"9226_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cncr.20737","volume":"105","author":"BA Centeno","year":"2005","unstructured":"Centeno BA, Enkemann SA, Coppola D, et al. Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples. Cancer 2005;105:101\u20139","journal-title":"Cancer"},{"key":"9226_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9440(10)63090-8","volume":"164","author":"G Bloom","year":"2004","unstructured":"Bloom G, Yang IV, Boulware D, et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 2004;164:9\u201316","journal-title":"Am J Pathol"},{"key":"9226_CR7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.ejca.2004.07.024","volume":"40","author":"PA Clarke","year":"2004","unstructured":"Clarke PA, te Poele R, Workman P. Gene expression microarray technologies in the development of new therapeutic agents. Eur J Cancer 2004;40:2560\u201391","journal-title":"Eur J Cancer"},{"key":"9226_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1359-6446(03)02654-0","volume":"8","author":"Y Huang","year":"2003","unstructured":"Huang Y, Sadee W. Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach. Drug Discov Today 2003;8:356\u201363","journal-title":"Drug Discov Today"},{"key":"9226_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drup.2004.06.004","volume":"7","author":"MA Alaoui-Jamali","year":"2004","unstructured":"Alaoui-Jamali MA, Dupre I, Qiang H. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling. Drug Resist Updat 2004;7:245\u201355","journal-title":"Drug Resist Updat"},{"key":"9226_CR10","first-page":"8791","volume":"63","author":"JM Mariadason","year":"2003","unstructured":"Mariadason JM, Arango D, Shi Q, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 2003;63:8791\u2013812","journal-title":"Cancer Res"},{"issue":"1","key":"9226_CR11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jcb.20789","volume":"98","author":"NR Monks","year":"2006","unstructured":"Monks NR, Pardee AB. Targeting the NF-kappaB pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem 2006;98(1):221\u201333","journal-title":"J Cell Biochem"},{"key":"9226_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jcb.20080","volume":"92","author":"NR Monks","year":"2004","unstructured":"Monks NR, Biswas DK, Pardee AB. Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target. J Cell Biochem 2004;92:646\u201350","journal-title":"J Cell Biochem"},{"key":"9226_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1568006033481384","volume":"3","author":"JP Kolb","year":"2003","unstructured":"Kolb JP, Kern C, Quiney C, et al. Re-establishment of a normal apoptotic process as a therapeutic approach in B-CLL. Curr Drug Targets Cardiovasc Haematol Disord 2003;3:261\u201386","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"9226_CR14","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/sj.onc.1204392","volume":"20","author":"I D\u2019Agnano","year":"2001","unstructured":"D\u2019Agnano I, Valentini A, Fornari C, et al. Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels. Oncogene 2001;20:2814\u201325","journal-title":"Oncogene"},{"key":"9226_CR15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1736","volume":"5","author":"SW Fesik","year":"2005","unstructured":"Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 2005;5:876\u201385","journal-title":"Nat Rev Cancer"},{"key":"9226_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00018-004-4365-8","volume":"62","author":"H Jonsson","year":"2005","unstructured":"Jonsson H, Peng SL. Forkhead transcription factors in immunology. Cell Mol Life Sci 2005;62:397\u2013409","journal-title":"Cell Mol Life Sci"},{"key":"9226_CR17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0092-8674(00)80540-1","volume":"90","author":"M Kaghad","year":"1997","unstructured":"Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809\u201319","journal-title":"Cell"},{"key":"9226_CR18","first-page":"3257","volume":"59","author":"AI Zaika","year":"1999","unstructured":"Zaika AI, Kovalev S, Marchenko ND, Moll UM. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res 1999;59:3257\u201363","journal-title":"Cancer Res"},{"key":"9226_CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/carcin\/21.4.683","volume":"21","author":"YC Cai","year":"2000","unstructured":"Cai YC, Yang GY, Nie Y, et al. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 2000;21:683\u20139","journal-title":"Carcinogenesis"},{"key":"9226_CR20","first-page":"319","volume":"13","author":"M Sunahara","year":"1998","unstructured":"Sunahara M, Ichimiya S, Nimura Y, et al. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. Int J Oncol 1998;13:319\u201323","journal-title":"Int J Oncol"},{"key":"9226_CR21","first-page":"2791","volume":"59","author":"SG Chi","year":"1999","unstructured":"Chi SG, Chang SG, Lee SJ, et al. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res 1999;59:2791\u20133","journal-title":"Cancer Res"},{"key":"9226_CR22","first-page":"3352","volume":"59","author":"PG Corn","year":"1999","unstructured":"Corn PG, Kuerbitz SJ, van Noesel MM, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5\u2032 CpG island methylation. Cancer Res 1999;59:3352\u20136","journal-title":"Cancer Res"},{"key":"9226_CR23","first-page":"1113","volume":"94","author":"S Kawano","year":"1999","unstructured":"Kawano S, Miller CW, Gombart AF, et al. Loss of p73 gene expression in leukemias\/lymphomas due to hypermethylation. Blood 1999;94:1113\u201320","journal-title":"Blood"},{"key":"9226_CR24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/416560a","volume":"416","author":"ER Flores","year":"2002","unstructured":"Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560\u20134","journal-title":"Nature"},{"key":"9226_CR25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1535-6108(03)00078-3","volume":"3","author":"MS Irwin","year":"2003","unstructured":"Irwin MS, Kondo K, Marin MC, et al. Chemosensitivity linked to p73 function. Cancer Cell 2003;3:403\u201310","journal-title":"Cancer Cell"},{"key":"9226_CR26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0960-9822(02)70791-4","volume":"6","author":"SA Marsters","year":"1996","unstructured":"Marsters SA, Sheridan JP, Donahue CJ, et al. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 1996;6:1669\u201376","journal-title":"Curr Biol"},{"key":"9226_CR27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0959-8049(01)00347-1","volume":"38","author":"A Eggert","year":"2002","unstructured":"Eggert A, Grotzer MA, Zuzak TJ, et al. Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system. Eur J Cancer 2002;38:92\u20138","journal-title":"Eur J Cancer"},{"key":"9226_CR28","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1073\/pnas.94.9.4615","volume":"94","author":"GR Screaton","year":"1997","unstructured":"Screaton GR, Xu XN, Olsen AL, et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 1997;94:4615\u20139","journal-title":"Proc Natl Acad Sci USA"},{"key":"9226_CR29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.cdd.4401416","volume":"11","author":"M Chawla-Sarkar","year":"2004","unstructured":"Chawla-Sarkar M, Bae SI, Reu FJ, et al. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L\/TRAIL-induced apoptosis. Cell Death Differ 2004;11:915\u201323","journal-title":"Cell Death Differ"},{"key":"9226_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/0008-5472.CAN-03-1656","volume":"64","author":"S Fulda","year":"2004","unstructured":"Fulda S, Debatin KM. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 2004;64:337\u201346","journal-title":"Cancer Res"},{"key":"9226_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1167\/iovs.03-1285","volume":"45","author":"DH Ren","year":"2004","unstructured":"Ren DH, Mayhew E, Hay C, et al. Uveal melanoma expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and susceptibility to TRAIL-induced apoptosis. Invest Ophthalmol Vis Sci 2004;45:1162\u20138","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9226_CR32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0006-2952(03)00509-4","volume":"66","author":"XD Zhang","year":"2003","unstructured":"Zhang XD, Gillespie SK, Borrow JM, Hersey P. The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis. Biochem Pharmacol 2003;66:1537\u201345","journal-title":"Biochem Pharmacol"},{"key":"9226_CR33","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/sj.onc.1206456","volume":"22","author":"VN Ivanov","year":"2003","unstructured":"Ivanov VN, Bhoumik A, Ronai Z. Death receptors and melanoma resistance to apoptosis. Oncogene 2003;22:3152\u201361","journal-title":"Oncogene"},{"key":"9226_CR34","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.febslet.2005.02.041","volume":"579","author":"JJ Wu","year":"2005","unstructured":"Wu JJ, Zhang XD, Gillespie S, Hersey P. Selection for TRAIL resistance results in melanoma cells with high proliferative potential. FEBS Lett 2005;579:1940\u20134","journal-title":"FEBS Lett"},{"key":"9226_CR35","doi-asserted-by":"crossref","first-page":"22856","DOI":"10.1074\/jbc.M412483200","volume":"280","author":"KG Drosopoulos","year":"2005","unstructured":"Drosopoulos KG, Roberts ML, Cermak L, et al. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. J Biol Chem 2005;280:22856\u201367","journal-title":"J Biol Chem"},{"key":"9226_CR36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/1541-7786.MCR-04-0136","volume":"3","author":"P Horak","year":"2005","unstructured":"Horak P, Pils D, Haller G, et al. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer. Mol Cancer Res 2005;3:335\u201343","journal-title":"Mol Cancer Res"},{"key":"9226_CR37","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/carcin\/bgi164","volume":"26","author":"B Frank","year":"2005","unstructured":"Frank B, Hemminki K, Shanmugam KS, et al. Association of death receptor 4 haplotype 626C\u2013683C with an increased breast cancer risk. Carcinogenesis 2005;26:1975\u20137","journal-title":"Carcinogenesis"},{"key":"9226_CR38","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/sj.onc.1202933","volume":"18","author":"B Bilanges","year":"1999","unstructured":"Bilanges B, Varrault A, Basyuk E, et al. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 1999;18:3979\u201388","journal-title":"Oncogene"},{"key":"9226_CR39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2004.08.051","volume":"95","author":"D Cvetkovic","year":"2004","unstructured":"Cvetkovic D, Pisarcik D, Lee C, et al. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecol Oncol 2004;95:449\u201355","journal-title":"Gynecol Oncol"},{"key":"9226_CR40","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","volume":"96","author":"CM Perou","year":"1999","unstructured":"Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999;96:9212\u20137","journal-title":"Proc Natl Acad Sci USA"},{"key":"9226_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/cbt.2.3.399","volume":"2","author":"S Singhal","year":"2003","unstructured":"Singhal S, Amin KM, Kruklitis R, et al. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol Ther 2003;2:291\u20138","journal-title":"Cancer Biol Ther"},{"key":"9226_CR42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/1541-7786.MCR-05-0019","volume":"3","author":"E Basyuk","year":"2005","unstructured":"Basyuk E, Coulon V, Le Digarcher A, et al. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas. Mol Cancer Res 2005;3:483\u201392","journal-title":"Mol Cancer Res"},{"key":"9226_CR43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/scdb.2000.0165","volume":"11","author":"VJ Kidd","year":"2000","unstructured":"Kidd VJ, Lahti JM, Teitz T. Proteolytic regulation of apoptosis. Semin Cell Dev Biol 2000;11:191\u2013201","journal-title":"Semin Cell Dev Biol"},{"key":"9226_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205\u201319","journal-title":"Cell"},{"key":"9226_CR45","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1745-7270.2005.00108.x","volume":"37","author":"TJ Fan","year":"2005","unstructured":"Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005;37:719\u201327","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"9226_CR46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1258\/000456305774538238","volume":"42","author":"SM Harwood","year":"2005","unstructured":"Harwood SM, Yaqoob MM, Allen DA. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis. Ann Clin Biochem 2005;42:415\u201331","journal-title":"Ann Clin Biochem"},{"key":"9226_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/geno.1998.5494","volume":"53","author":"RW Johnstone","year":"1998","unstructured":"Johnstone RW, Tommerup N, Hansen C, et al. Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics 1998;53:241\u20133","journal-title":"Genomics"},{"key":"9226_CR48","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/MCB.17.7.3823","volume":"17","author":"SF Sells","year":"1997","unstructured":"Sells SF, Han SS, Muthukkumar S, et al. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol Cell Biol 1997;17:3823\u201332","journal-title":"Mol Cell Biol"},{"key":"9226_CR49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.embor.embor769","volume":"4","author":"I Garcia-Cao","year":"2003","unstructured":"Garcia-Cao I, Lafuente MJ, Criado LM, et al. Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep 2003;4:307\u201312","journal-title":"EMBO Rep"},{"key":"9226_CR50","doi-asserted-by":"crossref","first-page":"23363","DOI":"10.1074\/jbc.M503083200","volume":"280","author":"K Pruitt","year":"2005","unstructured":"Pruitt K, Ulku AS, Frantz K, et al. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 2005;280:23363\u201370","journal-title":"J Biol Chem"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9226-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-006-9226-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-006-9226-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T15:19:35Z","timestamp":1587309575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-006-9226-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,30]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3,30]]}},"alternative-id":["9226"],"URL":"https:\/\/doi.org\/10.1245\/s10434-006-9226-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,30]]}}}